Zydus Lifesciences consolidated net profit falls to Rs 518 crore in Q1

Published On 2022-08-13 03:30 GMT   |   Update On 2022-08-13 06:54 GMT

New Delhi: Zydus Lifesciences on Wednesday reported a 13 percent decline in consolidated net profit at Rs 518 crore for the first quarter ended June on account of lower sales in the domestic market.

The Gujarat-based firm had posted a net profit of Rs 597 crore in the April-June quarter of the last fiscal.

Revenue from operations however increased to Rs 4,073 crore in the June quarter as against Rs 4,002 crore in the year-ago period, Zydus Lifesciences said in a statement.

Registered revenues in the India market stood at Rs 1,817 crore in the first quarter, 6 per cent down year-on-year.

However, excluding sales of COVID related products, the business grew 12 per cent year-on-year.

Read also: Sun Pharma net profit up 43 percent at Rs 2,061 crore in Q1

"We are encouraged by our stable Q1 FY23 performance, particularly with the rebound in US business even as consumer wellness and emerging markets sustained growth momentum," Zydus Lifesciences Managing Director Sharvil Patel said.

India branded formulations business, adjusting for COVID impact delivered healthy growth, he added.

Read also: Zydus bags USFDA nod for Prochlorperazine Maleate Tablets



Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News